Jolt Health Inc.
Jolt Health Inc.
CSE Index:
NoCurrency:
CAD Jolt Health Inc., is a specialized health and wellness company offering pharmaceutical and therapeutic products with proven technologies for which it has the exclusive rights to produce, package and sell thoughout Europe, North America and the United Kingdom. Many of the products are market-ready, with proven history of significant sales. The Company is focused on the global sexual wellness and enhancement market.
Jolt Health Inc. (JOLT)
0.10
0.005 (5.26%)
Jolt Health Inc. (JOLT)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
8,000
Bid Price
0.08
Ask Price
0.12
Ask Size
2,000
Volume
129,451
Last Price
0.10
Tick
Net Change
0.005
Prev Close
0.095
Open
0.095
Day High
0.10
Day Low
0.095
52 Week High
0.10
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.10
Tick
Net Change
Prev Close
0.10
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
8,000
Bid Price
0.08
Ask Price
0.12
Ask Size
2,000
Volume
129,451
Last Price
0.10
Tick
Net Change
0.005
Prev Close
0.095
Open
0.095
Day High
0.10
Day Low
0.095
52 Week High
0.10
52 Week Low
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
0.10
Tick
Net Change
Prev Close
0.10
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| CIBC World Markets Inc. | 8,000 | 0.08 | 0.12 | 2,000 | TD Securities Inc. |
| Leede Jones Gable | 24,000 | 0.075 | 0.125 | 5,000 | National Bank Financial Inc. |
| Anonymous | 50,000 | 0.075 | 0.145 | 5,000 | Anonymous |
| Virtu Canada Corp. | 1,000 | 0.06 | 0.15 | 5,000 | National Bank Financial Inc. |
| Anonymous | 25,000 | 0.06 | 0.15 | 20,000 | TD Securities Inc. |
| Anonymous | 25,000 | 0.055 | 0.175 | 5,000 | National Bank Financial Inc. |
| National Bank Financial Inc. | 3,000 | 0.055 | 0.175 | 9,000 | Scotia Capital Inc. |
| TD Securities Inc. | 200,000 | 0.05 | 0.195 | 24,000 | TD Securities Inc. |
| Anonymous | 25,000 | 0.045 | 0.48 | 1,000 | TD Securities Inc. |
| Anonymous | 25,000 | 0.04 | 0.89 | 1,000 | TD Securities Inc. |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 8,000 | 0.08 | 0.12 | 2,000 | 1 |
| 2 | 74,000 | 0.075 | 0.125 | 5,000 | 1 |
| 2 | 26,000 | 0.06 | 0.145 | 5,000 | 1 |
| 2 | 28,000 | 0.055 | 0.15 | 25,000 | 2 |
| 1 | 200,000 | 0.05 | 0.175 | 14,000 | 2 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 11, 18:55 | 0.10 | 0.005 | 6,000 | Anonymous | Desjardins Securities Inc. | CSE |
| Apr 11, 18:55 | 0.10 | 0.005 | 1,000 | Anonymous | National Bank Financial Inc. | CSE |
| Apr 11, 18:55 | 0.10 | 0.005 | 19,000 | Anonymous | TD Securities Inc. | CSE |
| Apr 11, 14:46 | 0.10 | 0.005 | 4,000 | Leede Jones Gable | National Bank Financial Inc. | CSE |
| Apr 11, 14:46 | 0.10 | 0.005 | 26,000 | Leede Jones Gable | Desjardins Securities Inc. | CSE |
Company Info
Address
1780 - 355 Burrard Street
Vancouver, BC V6C 2G8
CanadaPhone
1-(604)343-2977Email
investors@love-pharma.comListing date
Friday, October 29, 2004Transfer Agent
Odyssey Trust CompanyInvestor Relations
General Investor InquiriesEmail
investors@love-pharma.comAuditor
Baker TillySEDAR Information
Filing Type
Any
News Releases
Management's Discussion & Analysis
Financial Statements
Material Change Report
Timeframe
1 week1 month3 month6 month1 yearAll Time
Jolt Health Inc.
Date:
Apr 29, 2024
Jolt Health Inc.
Date:
Apr 29, 2024
Jolt Health Inc.
Date:
May 1, 2023
Jolt Health Inc.
Date:
May 1, 2023
Jolt Health Inc.
Date:
May 2, 2022
Jolt Health Inc.
Date:
May 2, 2022
Jolt Health Inc.
Date:
Jan 26, 2021
Jolt Health Inc.
Date:
Jan 26, 2021
Jolt Health Inc.
Date:
Jan 28, 2020
Jolt Health Inc.
Date:
Jan 28, 2020
Jolt Health Inc.
Date:
Jan 28, 2019
Jolt Health Inc.
Date:
Jan 28, 2019
Jolt Health Inc.
Date:
Jan 31, 2018
Jolt Health Inc.
Date:
Jan 31, 2018
Jolt Health Inc.
Date:
Jan 27, 2017
Jolt Health Inc.
Date:
Jan 27, 2017
Jolt Health Inc.
Date:
Jan 26, 2016
Jolt Health Inc.
Date:
Jan 20, 2015
Jolt Health Inc.
Date:
Feb 21, 2014
Jolt Health Inc.
Date:
Jan 24, 2014
Jolt Health Inc.
Date:
Dec 14, 2012
Company Info
Address
1780 - 355 Burrard Street
Vancouver, BC V6C 2G8
CanadaPhone
1-(604)343-2977Email
investors@love-pharma.comListing date
Friday, October 29, 2004Transfer Agent
Odyssey Trust CompanyInvestor Relations
General Investor InquiriesEmail
investors@love-pharma.comAuditor
Baker TillyCapitalization
Issued & Outstanding:
6364377Reserved for Issuance:
3105338Company Officers
Tatiana Kovaleva, CFO
Douglas Taylor, Director
Mark Tommasi, Director
Gerald Tritt, Chief Executive Officer, Director
News Releases
20/02/2025
Jolt Announces Consolidation
26/07/2024
Jolt Health Inc. Financing Update
Bulletins
21/02/2025
2025-0218 - Consolidation - Jolt Health Inc. (JOLT)
Le 21 février/February 2025
Jolt Health Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty (20) pre-consolidated common shares.
As a result, the number of outstanding shares will be reduced to approximately 6,364,486 common shares.
The name and symbol will not change.
